Brecanavir
Подписчиков: 0, рейтинг: 0
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider |
|
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C33H41N3O10S2 |
| Molar mass | 703.82 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
|
| |
Brecanavir (INN; codenamed GW640385) is a protease inhibitor which has been studied for the treatment of HIV.
In December 2006, its developer, GlaxoSmithKline discontinued further development because of insurmountable issues regarding formulation.